Health - Google News: FDA reviewers spot safety concerns with Sanofi, Isis lipid drug - Reuters

Health - Google News Google News

FDA reviewers spot safety concerns with Sanofi, Isis lipid drug - Reuters Oct 16th 2012, 18:55 Boston Globe FDA reviewers spot safety concerns with Sanofi, Isis lipid drug Reuters (Reuters) - U.S. drug reviewers flagged several safety concerns, including possible cancer risks, related to Sanofi SA and Isis Pharmaceuticals Inc's lipid disorder drug Kynamro, sending Isis's shares down as much as 21 percent. In briefing documents posted ... Isis Pharma tumbles on Kynamro cancer concernsBusinessweek 1 Stock Crumbling Ahead of FDA Committee MeetingsDailyFinance Isis down 20 percent after FDA report on Kynamro releasedU-T San Diego Wall Street Journal -Forbes -Minyanville.com all 49 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: